METAPROTERENOL Drug Patent Profile

When do Metaproterenol patents expire, and what generic alternatives are available?

Metaproterenol is a drug marketed by Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Chartwell, Cosette, G And W Labs Inc, Morton Grove, Am Therap, Heritage Pharma, Strides Pharma Intl, Usl Pharma, and Watson Labs. and is included in twenty-nine NDAs.

The generic ingredient in METAPROTERENOL is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Metaproterenol

A generic version of METAPROTERENOL was approved as metaproterenol sulfate by CHARTWELL on July 22^nd, 1992.

Summary for METAPROTERENOL

US Patents:	0
Applicants:	15
NDAs:	29
Drug Prices:	Drug price information for METAPROTERENOL
DailyMed Link:	METAPROTERENOL at DailyMed

See drug prices for METAPROTERENOL

US Patents and Regulatory Information for METAPROTERENOL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Usl Pharma	METAPROTERENOL SULFATE	metaproterenol sulfate	TABLET;ORAL	071014-001	Jan 25, 1988		DISCN	No	No
Watson Labs	METAPROTERENOL SULFATE	metaproterenol sulfate	TABLET;ORAL	073013-001	Jan 31, 1991		DISCN	No	No
Apotex Inc	METAPROTERENOL SULFATE	metaproterenol sulfate	SOLUTION;INHALATION	075402-001	Feb 28, 2001		DISCN	No	No
G And W Labs Inc	METAPROTERENOL SULFATE	metaproterenol sulfate	SYRUP;ORAL	073034-001	Aug 30, 1991		DISCN	No	No
Heritage Pharma	METAPROTERENOL SULFATE	metaproterenol sulfate	TABLET;ORAL	072520-001	Mar 30, 1990		DISCN	No	No
Dey	METAPROTERENOL SULFATE	metaproterenol sulfate	SOLUTION;INHALATION	070805-001	Aug 17, 1987		DISCN	No	No
Astrazeneca	METAPROTERENOL SULFATE	metaproterenol sulfate	SOLUTION;INHALATION	071018-001	Jul 27, 1988		DISCN	No	No